Stokes Family Office’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,422
Closed -$449K 287
2025
Q4
$449K Sell
4,422
-353
-7% -$28.3K 0.04% 207
2025
Q3
$261K Buy
4,775
+258
+6% +$12.9K 0.02% 231
2025
Q2
$240K Buy
+4,517
New +$229K 0.03% 213
2025
Q1
Sell
-4,413
Closed -$248K 239
2024
Q4
$248K Hold
4,413
0.03% 212
2024
Q3
$301K Buy
+4,413
New +$249K 0.03% 191
2024
Q2
Sell
-4,413
Closed -$305K 225
2024
Q1
$305K Hold
4,413
0.04% 185
2023
Q4
$326K Sell
4,413
-1,709
-28% -$112K 0.04% 168
2023
Q3
$418K Hold
6,122
0.05% 203
2023
Q2
$575K Hold
6,122
0.07% 160
2023
Q1
$415K Hold
6,122
0.05% 189
2022
Q4
$303K Buy
+6,122
New +$250K 0.04% 215
2022
Q3
Sell
-6,538
Closed -$258K 279
2022
Q2
$258K Buy
6,538
+2,100
+47% +$112K 0.04% 227
2022
Q1
$310K Hold
4,438
0.04% 204
2021
Q4
$345K Hold
4,438
0.04% 176
2021
Q3
$424K Buy
4,438
+72
+2% +$7.6K 0.06% 160
2021
Q2
$543K Hold
4,366
0.08% 135
2021
Q1
$575K Sell
4,366
-2
-0% -$274 0.09% 123
2020
Q4
$579K Buy
4,368
+15
+0.3% +$1.81K 0.11% 108
2020
Q3
$444K Hold
4,353
0.1% 108
2020
Q2
$378K Buy
4,353
+53
+1% +$4.24K 0.1% 108
2020
Q1
$249K Sell
4,300
-12
-0.3% -$974 0.07% 108
2019
Q4
$399K Buy
+4,312
New +$379K 0.09% 104

Other funds holding EXAS

Stokes Family Office's EXAS Position: Q1 2026 in Review

Stokes Family Office sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,422 shares — an estimated $449K sold.

Stokes Family Office first reported a position in EXAS in Q4 2019 and held it in 22 quarters. The position peaked at $579K in Q4 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Stokes Family Office reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Stokes Family Office sold 4,422 Exact Sciences shares in Q1 2026, an estimated $449K.
  • Stokes Family Office first reported a position in Exact Sciences in Q4 2019 and held it in 22 quarters.
  • Stokes Family Office's Exact Sciences position peaked at $579K in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Stokes Family Office's 13F filing for Q1 2026, filed 12 May 2026.